An MRI of a brain tumor
inviCRO has raised $45.8 million in its first disclosed financing. The money will be used to offer imaging services and analysis to aid drug research and development, according to a regulatory filing.
This news comes just after the Boston-based startup acquired Molecular Neuroimaging (MNI), expanding its neurological imaging options.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
As Fierce Medical Devices reported, inviCRO helped open the Translational Imaging Center in Mattawan, MI that it co-manages with MNI Research and 3D Imaging; inviCRO provides molecular imaging, while 3D imaging offers radiopharmaceutical services and MNI contributes its CRO services.
The company is continuing to expand, considering last year it also acquired a Seattle-based histology team.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
